Primary antibodies included mouse anti-glutamine synthetase (GS) (MAB302, 1:1000; Millipore, Darmstadt, Germany), mouse anti-glial fibrillary acidic protein (GFAP) (3670, 1:200; Cell Signaling Technology, Danvers, MA, USA), rabbit anti-GFAP (Z0334, 1:500; Dako, Carpinteria, CA, USA), rabbit anti-IBA-1 (019-19741, 1:500; Wako, Richmond, VA, USA), rabbit anti-VEGF (A20, 1:200; Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-PAX6 (1:500; developed by Kawakami, Developmental Studies Hybridoma Iowa City, IA, USA), and rabbit anti-Vimentin (ab45939, 1:300; ABCAM, Cambridge, MA, USA). Secondary antibodies were used at 1:500 room temperature (RT) or 1:1000 4°C overnight (Jackson ImmunoResearch, West Grove, PA, USA). Stains included Isolectin GS-B4 Alexa 568 (I21412, 1:200; Invitrogen, Grand Island, NY, USA), 4′,6-diamidino-2-phenylindole (DAPI) (4083, 1:50,000 from 1 mg/mL stock; Cell Signaling Technology), DRAQ5 (62251, 1:2000; Thermo Scientific, Waltham, MA, USA).